LEUCINE — all Canadian products
8 DINs
1 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is LEUCINE, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 00872296 | TRAVASOL | BAXTER CORPORATION | Solution | Intravenous | LEUCINE 730 MG; PHENYLALANINE 560 MG; METHIONINE 400 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 580 MG; ISOLEUCINE 600 MG; VALINE 580 MG; HISTIDINE 480 MG; THREONINE 420 MG; TRYPTOPHAN 180 MG; L-ALANINE 2.07 G; GLYCINE 1.03 G; ARGININE 1.15 G; PROLINE 680 MG; TYROSINE 40 MG; SERINE 500 MG | Marketed | |
| 00607800 | AMINO SOLUTION INJ | MULTIVET LTD/LTEE | Solution | Intravenous | LEUCINE 4 MG; ISOLEUCINE 2 MG; THREONINE 2 MG; LYSINE 4 MG; TRYPTOPHAN 1 MG; PHENYLALANINE 3 MG; HISTIDINE 1.4 MG; DL-METHIONINE 1 MG; ARGININE 2 MG; DEXTROSE 5 G; SODIUM ACETATE 250 MG; CALCIUM CHLORIDE 15 MG; MAGNESIUM SULFATE 20 MG; VITAMIN B1 10 MG; VITAMIN B2 4 MG; NICOTINAMIDE 150 MG; CALCIUM D-PANTOTHENATE 5 MG; VITAMIN B6 10 MG; VITAMIN B12 5 MCG; VALINE 3 MG | Cancelled Post Market | |
| 00890901 | BCAA 4% INJ | BAXTER CORPORATION | Liquid | Intravenous | LEUCINE 1.38 G; ISOLEUCINE 1.38 G; VALINE 1.24 G | Cancelled Post Market | |
| 00388769 | TRAVASOL | BAXTER CORPORATION | Solution | Intravenous | LEUCINE 620 MG; PHENYLALANINE 620 MG; METHIONINE 580 MG; L-LYSINE HYDROCHLORIDE 580 MG; ISOLEUCINE 480 MG; VALINE 460 MG; HISTIDINE 440 MG; THREONINE 420 MG; TRYPTOPHAN 180 MG; L-ALANINE 2.08 G; GLYCINE 2.08 G; ARGININE 1.04 G; PROLINE 420 MG; TYROSINE 40 MG | Cancelled Post Market | |
| 00306436 | TRAVASOL AMINO ACID INJ 8.5% | BAXTER CORPORATION | Solution | Intravenous | LEUCINE 526 MG; PHENYLALANINE 526 MG; METHIONINE 492 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 492 MG; ISOLEUCINE 406 MG; VALINE 390 MG; HISTIDINE 372 MG; THREONINE 356 MG; TRYPTOPHAN 152 MG; ALANINE 1.76 G; GLYCINE 1.76 G; ARGININE 880 MG; PROLINE 356 MG; TYROSINE 34 MG; SODIUM ACETATE 594 MG; POTASSIUM PHOSPHATE DIBASIC 522 MG; SODIUM CHLORIDE 154 MG; MAGNESIUM CHLORIDE 102 MG | Cancelled Post Market | |
| 00285528 | TRAVASOL E | BAXTER CORPORATION | Solution | Intravenous | LEUCINE 620 MG; PHENYLALANINE 620 MG; METHIONINE 580 MG; L-LYSINE (L-LYSINE HYDROCHLORIDE) 580 MG; ISOLEUCINE 480 MG; VALINE 460 MG; HISTIDINE 440 MG; THREONINE 420 MG; TRYPTOPHAN 180 MG; ALANINE 2.08 G; GLYCINE 2.08 G; ARGININE 1.04 G; PROLINE 420 MG; TYROSINE 40 MG; SODIUM ACETATE 680 MG; POTASSIUM PHOSPHATE DIBASIC 522 MG; SODIUM CHLORIDE 117 MG; MAGNESIUM CHLORIDE 102 MG | Cancelled Post Market | |
| 00388742 | TRAVASOL INJ WITHOUT ELECTROLYTES 5.5% | BAXTER CORPORATION | Solution | Intravenous | LEUCINE 340 MG; PHENYLALANINE 340 MG; METHIONINE 318 MG; L-LYSINE HYDROCHLORIDE 318 MG; ISOLEUCINE 263 MG; VALINE 252 MG; HISTIDINE 241 MG; THREONINE 230 MG; TRYPTOPHAN 99 MG; L-ALANINE 1.14 G; GLYCINE 1.14 G; ARGININE 570 MG; PROLINE 230 MG; TYROSINE 22 MG | Cancelled Post Market | |
| 00388750 | TRAVASOL INJ WITHOUT ELECTROLYTES 8.5% | BAXTER CORPORATION | Solution | Intravenous | LEUCINE 526 MG; PHENYLALANINE 526 MG; DL-METHIONINE 492 MG; L-LYSINE HYDROCHLORIDE 492 MG; ISOLEUCINE 406 MG; VALINE 390 MG; HISTIDINE 372 MG; THREONINE 356 MG; TRYPTOPHAN 152 MG; L-ALANINE 1.76 G; GLYCINE 1.76 G; ARGININE 880 MG; PROLINE 356 MG; TYROSINE 34 MG | Cancelled Post Market |
Browse other molecules: